A detailed history of Two Sigma Investments, LP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 356,050 shares of CORT stock, worth $18.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
356,050
Previous 393,780 9.58%
Holding current value
$18.6 Million
Previous $12.8 Million 28.74%
% of portfolio
0.04%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$29.51 - $46.26 $1.11 Million - $1.75 Million
-37,730 Reduced 9.58%
356,050 $16.5 Million
Q2 2024

Aug 14, 2024

SELL
$22.21 - $34.48 $9.43 Million - $14.6 Million
-424,695 Reduced 51.89%
393,780 $12.8 Million
Q1 2024

May 15, 2024

BUY
$21.1 - $27.46 $7.19 Million - $9.36 Million
340,918 Added 71.39%
818,475 $20.6 Million
Q4 2023

Feb 14, 2024

BUY
$24.82 - $32.88 $5.52 Million - $7.31 Million
222,292 Added 87.08%
477,557 $15.5 Million
Q3 2023

Nov 14, 2023

BUY
$21.97 - $33.8 $1.77 Million - $2.73 Million
80,721 Added 46.25%
255,265 $6.96 Million
Q2 2023

Aug 14, 2023

BUY
$21.44 - $25.15 $3.74 Million - $4.39 Million
174,544 New
174,544 $3.88 Million
Q2 2020

Aug 14, 2020

SELL
$11.0 - $18.26 $116,094 - $192,716
-10,554 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$10.11 - $14.04 $106,700 - $148,178
10,554 New
10,554 $125,000
Q2 2019

Aug 14, 2019

SELL
$9.78 - $12.76 $181,878 - $237,297
-18,597 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$10.03 - $15.71 $186,527 - $292,158
18,597 New
18,597 $218,000
Q1 2018

May 15, 2018

SELL
$14.59 - $25.5 $1.95 Million - $3.41 Million
-133,732 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$15.77 - $20.72 $3.68 Million - $4.83 Million
-233,167 Reduced 63.55%
133,732 $2.42 Million
Q3 2017

Nov 14, 2017

BUY
$12.3 - $19.3 $4.51 Million - $7.08 Million
366,899
366,899 $7.08 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.59B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.